Shanghai Xiao Fang Pharmaceutical Co.,Ltd. (SHA:603207)
China
· Delayed Price · Currency is CNY 29.07
+0.08 (0.28%)
At close: Jun 12, 2025, 2:57 PM CST
SHA:603207 Revenue
Shanghai Xiao Fang Pharmaceutical had revenue of 129.07M CNY in the quarter ending March 31, 2025, a decrease of -0.71%. This brings the company's revenue in the last twelve months to 478.74M. In the year 2024, Shanghai Xiao Fang Pharmaceutical had annual revenue of 474.58M with 0.57% growth.
Revenue (ttm)
478.74M
Revenue Growth
+0.57%
P/S Ratio
9.69
Revenue / Employee
1.19M
Employees
404
Market Cap
4.64B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Kweichow Moutai | 175.72B |
| China Merchants Bank | 295.79B |
| Contemporary Amperex Technology | 366.95B |
| Ping An Insurance (Group) Company of China | 945.67B |
| China Yangtze Power | 85.85B |
| Midea Group | 428.89B |
| Industrial Bank | 151.04B |
| Wuliangye Yibin | 91.28B |